Menu
Clinical translation at cost price, business development support and regulatory guidance for promising Life Science ventures.
If accepted, you receive full support in the (pre-) clinical translation of your compound at cost price, business development support and regulatory guidance.
We will manage the clinical translation of your compound till phase III at cost price, starting by generating fast in-human data on the efficacy of your drug. This saves up to 40% of the regular R&D costs. Additionally, TRACER does not gain equity nor requires IP sharing from the participating companies.
Together will define business goals for your venture to generate a high return on investment for all stakeholders involved. As a participant you are also introduced to a large European and U.S. network. This allows you to expand your strategic partnerships and find potential exit partners.
Our team has extensive know-how in creating the most efficient regulatory path for testing a new drug. They will advise you on how to develop your compound in a way that fits the market and will, together with you, develop FDA and/or EMA compliant clinical development plans.
You will work closely together with a team that has many years of experience in the Life Sciences industry in both international business and scientific expertise.
A pioneer in the optical imaging field with ground breaking research to his name.
A life science veteran with 25+ years of international experience in the industry.
A seasoned scientist, specialised in chemistry and nuclear imaging.
Got any questions? Don't hesitate to reach out.